The commercial platform for healthcare

Sell more. Waste less.

We help pharmaceutical and medical device sales teams find, target, and close the right accounts faster.

Real customer outcomes.

The numbers speak for themselves.

+106%

Increase in prospect engagement

42%

Conversion rate on prospect targeting

5 hrs

Saved per week per rep on prospect research

+23.6%

Monthly revenue uplift after switching to Rare.

Source: Rare.Monitor users 2025-2026.

Trusted by the best in the business

"The Rare. strength is a combination of large data samples, strong data analytics & insight generation capabilities and, importantly, ability to listen to the customer needs and give us clear options based on that. This makes Rare: a high quality thought partner."

Anton Petrov

Brand Director, L'Oreal

"I have worked with Rare.Monitor during my previous and current role. It has provided unparalleled access to market insights for both strategic planning and supporting my teams to expand their customer base. The team at Rare. are super responsive to feedback and provide excellent support to optimise the tools. We also use the data to support our existing clients with business planning by looking at their local competitive landscape to help them find new opportunities. I would have loved access to this when I was a sales rep, now I get to empower my team with high quality data and remove the time consuming task of hunting for new prospects on Google and Socials instead."

Natalie Colbourne

Director of Commercial Programmes and Strategy, Establishment Labs

"Their methodology was robust throughout and I was very impressed by their attention to detail and implementation plans for rollout to the broader team. I highly recommend partnering with the Rare: team!"

Isabel Diez-Sevilla

Business Insights & Analytics Manager, Daiichi Sankyo UK

"Proud to see SUNEKOS among the top 5 most mentioned injectable brands in the UK. A result that reflects the professionalism, perseverance, and scientific integrity that define our work every day at Professional Dietetics. Great Analysis!"

Tiziano Cameroni

C.E.O. & Co-Owner, Professional Dietetics

L'Oreal
Alibreo
MAP Health
NHS
The London Clinic
Galderma
Vivacy
Align Technology
Alma
Members of
  • MRS
  • ABPI
  • BHBIA

Find prospects. Track accounts. Close faster.

Rare.Monitor gives your commercial team one place to find new prospects, manage accounts, and track what's working, across over 160,000 UK and Ireland healthcare providers. Live market data and account management built into the same workflow, so your reps act on insight the moment they see it.

Find prospects. Track accounts. Close faster.

Three things commercial teams notice within the first month

Why RARE.

01

Built for commercial teams in private healthcare

Not a generic CRM, not a research subscription. Rare.Monitor mirrors how pharma and medical device teams actually work: targeting accounts, prioritising opportunities, reading the channel.

02

Live data, not last year's report

The provider dataset behind Rare.Monitor refreshes daily.

03

One source of truth

Prospecting, account management, and live market intelligence on UK private healthcare. No system-hopping between tools.

Ready to double your revenue?

Our clients have. Book a demo and we'll show you how Rare.Monitor helped one team increase rep revenue by 98%.

Latest

Insights

Brand Analysis methodology
Blog Read now

Brand Analysis methodology

Why Brand Analysis exists, and how it works. Manufacturers in healthcare practitioner channels have no running brand-impact metrics; Rare.Monitor's Brand Analysis was built for that gap. This piece explains the three per-brand metrics (Score, Penetration, Mention Rate), Coverage as a database-level reference, and what Brand Analysis does and does not measure. Read this before using any Brand Analysis report from Rare.Monitor.

9 May 2026

Republic of Ireland medical-grade skincare brand amplification donut chart, May 2026 (v2 with ROI terminology)
Blog Register to read

Brand analysis: Republic of Ireland medical-grade skincare, May 2026

Image International Manufacturing's Image Skincare tops the Republic of Ireland medical-grade skincare ranking with a mention rate of 52.4% in May 2026. Obagi Medical's Obagi is second on 22.7%, Alumier Labs' AlumierMD third on 16.7%, Unilever's Dermalogica fourth on 15.8%. Top 10 medical-grade skincare brands ranked across 444 ROI clinics that name a medical-grade skincare brand on their website. Rare.Monitor Brand Analysis.

8 May 2026

Horizontal bar chart of Mention Rate by manufacturer in UK clinics that name an HA filler brand on their website. Analysis of 19,289 UK dermal filler clinics, n=3,648. Rare.Monitor Brand Analysis, May 2026.
Brand amplification Register to read

Brand analysis: UK Hyaluronic Acid (HA) dermal fillers, May 2026

Allergan/AbbVie's Juvéderm leads the UK cross-linked hyaluronic acid dermal filler ranking with a 66.1% clinic mention rate in May 2026. Galderma's Restylane sits second on 45.1%, Teoxane's Teosyal third on 28.7%. Based on Rare: Monitor's audit of 19,289 UK dermal filler clinics, n=3,648 brand-naming clinics. Cross-linked HA fillers only; bioremodellers reported separately.

8 May 2026